Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2000
03/15/2000CN1247473A Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
03/15/2000CN1247191A Imidazolium compound as synthetic material of imidazole lipoxidase inhibitor
03/15/2000CN1247076A Medical capsules for treating asthma
03/15/2000CN1050283C Gel-type cosmetic composite
03/14/2000US6037470 Purine compounds having PDE IV inhibitory activity and methods of synthesis
03/14/2000US6037377 Antiinflammatory agents and antiallergens
03/14/2000US6037363 Respiratory system disorders, cystic fibrosis
03/14/2000US6037325 Certain substituted oxadiazole, thiadiazole and triazole peptoids used effectively to prevent, alleviate or otherwise treat disease states characterized by the degradation of connective tissue such as respiratory system disorders and
03/14/2000US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion
03/14/2000US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma
03/14/2000CA2008263C Pyrazolopyridine compound and processes for preparation thereof
03/09/2000WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012703A2 Protein transport-associated molecules
03/09/2000WO2000012562A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES
03/09/2000WO2000012525A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000WO2000012514A1 Novel compounds
03/09/2000WO2000012502A1 Pyrroloquinolines for treatment of obesity
03/09/2000WO2000012501A1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012475A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000WO2000012139A1 Hypoxia regulated genes
03/09/2000WO2000012130A1 Rp105 agonists and antagonists
03/09/2000WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000012090A1 THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS
03/09/2000WO2000012078A1 Therapies for treating pulmonary diseases
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000WO2000012049A2 A method for the treatment of staphylococcal disease
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2629396A1 The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2342245A1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
03/09/2000CA2341986A1 Pyrroloquinolines for treatment of obesity
03/09/2000CA2341705A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000CA2341699A1 A method for the treatment of staphylococcal disease
03/09/2000CA2341525A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/09/2000CA2341518A1 Hypoxia regulated genes
03/09/2000CA2341488A1 Therapies for treating pulmonary diseases
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983262A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
03/08/2000EP0983260A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
03/08/2000EP0983251A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
03/08/2000EP0983249A1 Processes and intermediates for preparing substituted indazole derivatives
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983064A1 PYRROLES AS sPLA2 INHIBITORS
03/08/2000EP0983058A1 Medicinal aerosol products
03/08/2000CN1246866A Monocyclic compounds with four bifunctional residues having NK-2 antagonist action
03/08/2000CN1246857A Substituted pyrimidinone and pyridinone compounds and their use
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246855A Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
03/08/2000CN1246794A Lactose-free, non-hyproscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
03/08/2000CN1246793A Method and compositions for treating allergic asthma and other diseases using descartoethoxyloratadine
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1246366A Medical capsule for treating nasosinusitis
03/08/2000CN1050132C Ginkgotide derivatives
03/08/2000CN1050129C Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
03/08/2000CN1050127C Benocycloheptenes and benzoxepines preparing process thereof and pharmaceutical compositions containing them
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034117 Administering acetyl choline esterase inhibitor
03/07/2000US6034113 Derivatives of 1,3,4-oxadiazolone
03/07/2000US6034107 5-Substituted picolinic acid compounds and their production process
03/07/2000US6034094 Pharmaceutically useful 3,4-dihydroisoquinoline
03/07/2000US6034082 5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6034057 Cyclic octapeptide; antiarthritic agent
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033688 Cystic fibrosis therapy
03/07/2000US6033685 Tablet for the controlled release of active agents
03/07/2000US6033668 Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
03/07/2000US6033667 Method for detecting the presence of P-selectin
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010982A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000WO2000010981A1 Quinazoline derivatives
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010598A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion
03/02/2000WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010548A2 19-nor-vitamin d3 compounds with calcemic activity
03/02/2000WO2000010544A2 A method for preventing the onset of asthma
03/02/2000WO2000010541A1 Stable spray-dried protein formulations
03/02/2000WO2000010536A1 Extended release buccal bioadhesive tablet
03/02/2000WO2000010529A1 Oral liquid mucoadhesive compositions
03/02/2000WO2000010528A1 Oral liquid mucoadhesive compositions
1 ... 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 ... 878